Factors involved in the development of fulminant hepatitis B : Are the mutations of hepatitis B virus implicated?
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-11-01
著者
-
INOUE Jun
Division of Gastroenterology, Tohoku University Graduate School of Medicine
-
Inoue Jun
Division Of Gastroenterology Tohoku University Graduate School Of Medicine
関連論文
- A novel third generation bisphosphonate, minodronate (YM529), prevented proliferation and migration of hepatocellular carcinoma cells through inhibition of mevalonate pathway
- Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan
- Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases
- A case of HIV co-infected with hepatitis B virus precore/core deletion mutant treated by entecavir
- Living Related Liver Transplantation for Acute Fulminant Hepatitis B : Experience from Two Possible Hyper-Acute Cases
- Lack of common mutation in the alfa-subunit of the mitochondrial trifunctional protein and the polymorphism of CYP2E1 in three Japanese women with acute fatty liver of pregnancy/HELLP syndrome
- Nucleotide Substitutions of Hepatitis E Virus Genomes Associated with Fulminant Hepatitis and Disease Severity
- A case of severe recurrent hepatitis with common variable immunodeficiency
- The High Incidence of the Emergence of Entecavir-Resistant Mutants among Patients Infected with Lamivudine-Resistant Hepatitis B Virus
- Characterization of the epithelial cell adhesion molecule (EpCAM)^+ cell population in hepatocellular carcinoma cell lines
- The Nutritional Index 'CONUT' Is Useful for Predicting Long-Term Prognosis of Patients with End-Stage Liver Diseases
- Lymphotropic HCV strain can infect human primary naive CD4^+ cells and affect their proliferation and IFN-γ secretion activity
- Factors involved in the development of fulminant hepatitis B : Are the mutations of hepatitis B virus implicated?
- Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy
- Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients